Original Research
Published on 30 Oct 2020
The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes
in Cancer Immunity and Immunotherapy

- 3,581 views
- 6 citations
Original Research
Published on 30 Oct 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 30 Oct 2020
in Microbial Immunology

Original Research
Published on 30 Oct 2020
in Autoimmune and Autoinflammatory Disorders

Original Research
Published on 30 Oct 2020
in Inflammation

Original Research
Published on 30 Oct 2020
in NK and Innate Lymphoid Cell Biology

Hypothesis and Theory
Published on 30 Oct 2020
in Vaccines and Molecular Therapeutics

Original Research
Published on 30 Oct 2020
in Inflammation

Original Research
Published on 30 Oct 2020
in Inflammation

Review
Published on 30 Oct 2020
in B Cell Biology

Original Research
Published on 30 Oct 2020
in Vaccines and Molecular Therapeutics

Mini Review
Published on 30 Oct 2020
in Nutritional Immunology

Opinion
Published on 30 Oct 2020
in Viral Immunology
Review
Published on 30 Oct 2020
in Cancer Immunity and Immunotherapy

Editorial
Published on 30 Oct 2020
in Microbial Immunology
Original Research
Published on 30 Oct 2020
in Nutritional Immunology

Original Research
Published on 30 Oct 2020
in Primary Immunodeficiencies
